Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 2
1990 1
1991 1
1992 2
1994 2
1995 1
1996 1
1997 1
1999 3
2000 5
2001 2
2002 4
2003 4
2004 7
2005 6
2006 3
2007 8
2008 8
2009 11
2010 15
2011 20
2012 11
2013 9
2014 32
2015 49
2016 51
2017 51
2018 60
2019 82
2020 71
2021 82
2022 63
2023 91
2024 29

Text availability

Article attribute

Article type

Publication date

Search Results

699 results

Results by year

Filters applied: . Clear all
Page 1
Advances in Osteosarcoma.
Panez-Toro I, Muñoz-García J, Vargas-Franco JW, Renodon-Cornière A, Heymann MF, Lézot F, Heymann D. Panez-Toro I, et al. Curr Osteoporos Rep. 2023 Aug;21(4):330-343. doi: 10.1007/s11914-023-00803-9. Epub 2023 Jun 17. Curr Osteoporos Rep. 2023. PMID: 37329384 Free PMC article. Review.
However, the most recent clinical trials show a slight improvement over the conventional polychemotherapy scheme. The tumor microenvironment plays a crucial role in the pathogenesis of osteosarcoma by controlling the tumor growth, the metastatic process and the drug resist …
However, the most recent clinical trials show a slight improvement over the conventional polychemotherapy scheme. The tumor microenvironment …
Anatomy, Function, and Dysfunction of the Right Ventricle: JACC State-of-the-Art Review.
Sanz J, Sánchez-Quintana D, Bossone E, Bogaard HJ, Naeije R. Sanz J, et al. J Am Coll Cardiol. 2019 Apr 2;73(12):1463-1482. doi: 10.1016/j.jacc.2018.12.076. J Am Coll Cardiol. 2019. PMID: 30922478 Free article. Review.
There is increasing recognition of the crucial role of the right ventricle (RV) in determining functional status and prognosis in multiple conditions. ...
There is increasing recognition of the crucial role of the right ventricle (RV) in determining functional status and prognosis in mul …
Molecular mechanisms of antibody somatic hypermutation.
Di Noia JM, Neuberger MS. Di Noia JM, et al. Annu Rev Biochem. 2007;76:1-22. doi: 10.1146/annurev.biochem.76.061705.090740. Annu Rev Biochem. 2007. PMID: 17328676 Review.
Recognition of the U:G mismatch by MSH2/MSH6 triggers a mutagenic patch repair in which polymerase eta plays a major role and leads to mutations at A:T pairs. AID-triggered DNA deamination also underpins immunoglobulin variable (IgV) gene conversion, isotype class switchin …
Recognition of the U:G mismatch by MSH2/MSH6 triggers a mutagenic patch repair in which polymerase eta plays a major role and leads t …
Yersinia pestis and plague: an updated view on evolution, virulence determinants, immune subversion, vaccination, and diagnostics.
Demeure CE, Dussurget O, Mas Fiol G, Le Guern AS, Savin C, Pizarro-Cerdá J. Demeure CE, et al. Genes Immun. 2019 May;20(5):357-370. doi: 10.1038/s41435-019-0065-0. Epub 2019 Apr 3. Genes Immun. 2019. PMID: 30940874 Free PMC article. Review.
A complex set of virulence determinants, including the Yersinia outer-membrane proteins (Yops), the broad-range protease Pla, pathogen-associated molecular patterns (PAMPs), and iron capture systems play critical roles in the molecular strategies that Y. pestis employs to …
A complex set of virulence determinants, including the Yersinia outer-membrane proteins (Yops), the broad-range protease Pla, pathogen-assoc …
Production of monoclonal antibodies for therapeutic purposes: A review.
Alejandra WP, Miriam Irene JP, Fabio Antonio GS, Patricia RR, Elizabeth TA, Aleman-Aguilar JP, Rebeca GV. Alejandra WP, et al. Int Immunopharmacol. 2023 Jul;120:110376. doi: 10.1016/j.intimp.2023.110376. Epub 2023 May 25. Int Immunopharmacol. 2023. PMID: 37244118 Review.
Monoclonal antibodies (mAbs) have been used in the development of immunotherapies that target a variety of diseases, such as cancer, autoimmune diseases, and even viral infections; they play a key role in immunization and are expected after vaccination. However, some condi …
Monoclonal antibodies (mAbs) have been used in the development of immunotherapies that target a variety of diseases, such as cancer, autoimm …
Translation-coupled mRNA quality control mechanisms.
Monaghan L, Longman D, Cáceres JF. Monaghan L, et al. EMBO J. 2023 Oct 4;42(19):e114378. doi: 10.15252/embj.2023114378. Epub 2023 Aug 22. EMBO J. 2023. PMID: 37605642 Free PMC article. Review.
We also describe advances in our understanding of the nonsense-mediated mRNA decay (NMD) pathway, highlighting recent mechanistic findings, the discovery of novel factors, as well as the role of NMD in cellular physiology and its impact on human disease....
We also describe advances in our understanding of the nonsense-mediated mRNA decay (NMD) pathway, highlighting recent mechanistic findings, …
Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysis.
Dimopoulos MA, Moreau P, Augustson B, Castro N, Pika T, Delimpasi S, De la Rubia J, Maiolino A, Reiman T, Martinez-Lopez J, Martin T, Mikhael J, Yong K, Risse ML, Asset G, Marion S, Hajek R. Dimopoulos MA, et al. Am J Hematol. 2023 Jan;98(1):E15-E19. doi: 10.1002/ajh.26602. Epub 2022 Jun 4. Am J Hematol. 2023. PMID: 35604280 Free PMC article. No abstract available.
ASCO 2020.
Bartsch R, Dieras V, Cortes J, Müller V, Ruhstaller T. Bartsch R, et al. Breast Care (Basel). 2020 Aug;15(4):433-436. doi: 10.1159/000510051. Epub 2020 Jul 16. Breast Care (Basel). 2020. PMID: 32982656 Free PMC article. No abstract available.
Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer.
O'Shaughnessy J, Brufsky A, Rugo HS, Tolaney SM, Punie K, Sardesai S, Hamilton E, Loirat D, Traina T, Leon-Ferre R, Hurvitz SA, Kalinsky K, Bardia A, Henry S, Mayer I, Zhu Y, Phan S, Cortés J. O'Shaughnessy J, et al. Breast Cancer Res Treat. 2022 Sep;195(2):127-139. doi: 10.1007/s10549-022-06602-7. Epub 2022 May 11. Breast Cancer Res Treat. 2022. PMID: 35545724 Free PMC article. Clinical Trial.
699 results